AffiAB®​ Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)

Specifications

Technique
Antibody

Description

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293) .

Additional Attributes

Host
Human
Isotype
IgM
Technique
Antibody
Technique
Monoclonal
Brand
AffiAB